Antimicrobial Agents Practice Questions

Q: All of the following statements regarding the development of resistance against penicillins is true EXCEPT?

Bacteria may develop alternate metabolic pathways.. **Explanation:** The development of bacterial resistance to penicillins primarily involves mechanisms that interfere with the drug's ability to inhibit cell wall synthesis. **Why Option C is the correct answer:** Penicillins act by inhibiting the cross-linking of peptidoglycan in the bacterial cell wall. Unlike Sulfonamides (which inhibit folic acid synthesis), penicillins do not target metabolic pathways. Therefore, **developing alternate metabolic pathways** is a mechanism of resistance associated with **Sulfonamides and Trimethoprim**, not penicillins. **Why the other options are incorrect:** * **Option A (Inactivating enzymes):** This is the most common mechanism. Bacteria produce **$\beta$-lactamases (penicillinases)** that hydrolyze the $\beta$-lactam ring, rendering the drug inactive (e.g., *Staphylococcus aureus*). * **Option B (Altered PBPs):** Bacteria can modify the target site (Penicillin Binding Proteins). This is the hallmark mechanism for **MRSA** (Methicillin-resistant *S. aureus*) and penicillin-resistant *Streptococcus pneumoniae*. * **Option D (Reduced Permeability):** Gram-negative bacteria can change the size or charge of **porin channels** in their outer membrane, preventing the drug from reaching the PBPs (common in *Pseudomonas*). **High-Yield Clinical Pearls for NEET-PG:** 1. **MRSA Resistance:** Mediated by the **mecA gene**, which encodes an altered PBP called **PBP2a**, which has a low affinity for $\beta$-lactams. 2. **$\beta$-lactamase Inhibitors:** Drugs like Clavulanic acid, Sulbactam, and Tazobactam are used to overcome resistance caused by penicillinases (Option A) but are ineffective against resistance caused by altered PBPs (Option B). 3. **Efflux Pumps:** Another mechanism where bacteria actively pump the drug out of the cell (common in Tetracycline resistance).

Q: An elderly patient with tubercular meningitis is not responding to the current treatment. A new combination of drugs needs to be prescribed for a prolonged period. Which one of the following drugs should not be prescribed in this case?

Dehydrostreptomycin. **Explanation:** The correct answer is **Dehydrostreptomycin** because of its high risk of irreversible toxicity, particularly in elderly patients requiring long-term therapy. **1. Why Dehydrostreptomycin is the Correct Answer:** Dehydrostreptomycin is an aminoglycoside derivative that was historically used for tuberculosis. However, it is significantly more **ototoxic** than Streptomycin, specifically causing profound and permanent **cochlear damage (deafness)**. In an elderly patient where renal clearance is often reduced, the risk of accumulation and toxicity is even higher. Furthermore, aminoglycosides generally have poor penetration into the Cerebrospinal Fluid (CSF) unless the meninges are severely inflamed. Due to its severe toxicity profile, it has been largely replaced by safer alternatives. **2. Why the other options are incorrect:** * **Rifampicin:** A bactericidal "first-line" drug and the backbone of TB meningitis treatment. It penetrates the CSF well when meninges are inflamed. * **Ofloxacin:** A fluoroquinolone often used as a "second-line" agent in drug-resistant TB or when first-line drugs are not tolerated. It has excellent CSF penetration. * **Pyrazinamide:** A crucial first-line drug that achieves CSF concentrations nearly equal to plasma concentrations, making it highly effective for tubercular meningitis. **NEET-PG High-Yield Pearls:** * **Drug of Choice for TB Meningitis:** The standard regimen is HRZE (Isoniazid, Rifampicin, Pyrazinamide, Ethambutol). * **CSF Penetration:** Pyrazinamide and Isoniazid have the best CSF penetration among anti-TB drugs. * **Ototoxicity:** Aminoglycosides cause ototoxicity by damaging hair cells; Streptomycin is more vestibulotoxic, while Amikacin and Dehydrostreptomycin are more cochleotoxic. * **Elderly Caution:** Always prioritize drugs with lower toxicity profiles in the elderly due to age-related decline in eighth cranial nerve function and renal reserve.

Q: Gynaecomastia is a side effect of which of the following medications?

Rifampicin. **Explanation:** The correct answer is **Rifampicin**. While several drugs are classically associated with gynaecomastia, in the context of this specific question, Rifampicin is the correct choice due to its unique metabolic effects. **1. Why Rifampicin is Correct:** Rifampicin is a potent **inducer of hepatic microsomal enzymes (Cytochrome P450)**. It increases the metabolic clearance of testosterone and other androgens. Additionally, it can alter the ratio of estrogens to androgens in the body. This hormonal imbalance leads to the development of gynaecomastia in some patients undergoing anti-tubercular therapy (ATT). **2. Analysis of Other Options:** * **Digitalis:** While chronic use of Digoxin can cause gynaecomastia (due to its steroid-like structure which can bind to estrogen receptors), it is less frequently tested in this specific context compared to anti-infectives. * **Ketoconazole:** This is a classic cause of gynaecomastia. It inhibits the enzyme **17,20-desmolase**, thereby blocking the synthesis of adrenal and gonadal steroids (testosterone). * **Spironolactone:** This is perhaps the most common cause of drug-induced gynaecomastia. It acts as a **competitive antagonist at androgen receptors** and inhibits testosterone synthesis. *Note: In many standard exams, Spironolactone and Ketoconazole are more common answers. However, if Rifampicin is marked as the key, it highlights the importance of recognizing enzyme induction as a mechanism for hormonal side effects.* **3. High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Gynaecomastia (DISCO):** **D**igoxin, **I**soniazid, **S**pironolactone, **C**imetidine, **O**estrogens/Ketoconazole. * **Rifampicin** is also famous for causing **orange-red discoloration** of body fluids (urine, sweat, tears). * **Ketoconazole** is unique among antifungals for its anti-androgenic side effects, often used off-label for Cushing’s syndrome or prostate cancer.

Q: Which antibiotic can cause respiratory failure when used in patients with myasthenia gravis?

Telithromycin. **Explanation:** **Telithromycin**, a ketolide antibiotic derived from macrolides, is notorious for causing severe, life-threatening exacerbations of **Myasthenia Gravis (MG)**. The underlying mechanism involves the drug’s ability to block nicotinic acetylcholine receptors at the neuromuscular junction (NMJ). In patients with MG, who already have a reduced number of functional receptors, this blockade can precipitate a "myasthenic crisis," leading to acute respiratory failure. Consequently, the FDA has issued a **Black Box Warning** contraindicating its use in MG patients. **Analysis of Incorrect Options:** * **B. Clindamycin:** While lincosamides can theoretically potentiate neuromuscular blockade, they are not classically associated with the rapid, severe respiratory failure seen with Telithromycin in MG. * **C. Linezolid:** An oxazolidinone primarily known for causing bone marrow suppression (thrombocytopenia) and weak MAO inhibition (risk of Serotonin Syndrome). It does not significantly affect the NMJ. * **D. Tetracycline:** These can occasionally worsen MG by chelating calcium (required for ACh release), but they are far less potent in this regard than ketolides or aminoglycosides. **High-Yield Clinical Pearls for NEET-PG:** * **Aminoglycosides** (e.g., Gentamicin) are the most common class of antibiotics to avoid in MG as they inhibit the pre-synaptic release of Acetylcholine. * **Fluoroquinolones** (e.g., Ciprofloxacin) also carry a black box warning for MG exacerbation. * **Ketolides vs. Macrolides:** Telithromycin is structurally similar to Erythromycin but has a higher affinity for the NMJ receptors, making it significantly more dangerous for MG patients.

Q: Ideally, an antibiotic should focus on a microbial target not found in mammalian cells. By this standard, which of the following antibiotic agents would be expected to be most toxic to humans?

Mitomycin. **Explanation:** The core principle of antimicrobial chemotherapy is **selective toxicity**, which means a drug should be lethal to the microorganism without harming the host. This is best achieved by targeting structures or metabolic pathways present in microbes but absent in humans. **Why Mitomycin is the correct answer:** Mitomycin (specifically Mitomycin C) acts by cross-linking DNA, which inhibits DNA synthesis. Unlike cell wall inhibitors, its target—**DNA**—is universal to both microbial and mammalian cells. Because it lacks selective toxicity, it is highly toxic to human cells. Consequently, Mitomycin is not used as an antibacterial agent; instead, it is utilized as a **chemotherapeutic (anti-cancer) drug** to kill rapidly dividing human tumor cells. **Why the other options are incorrect:** * **Penicillin & Cephalosporins (Beta-lactams):** These inhibit the synthesis of **peptidoglycan**, a structural component of the bacterial cell wall. Since mammalian cells do not possess a cell wall or peptidoglycan, these drugs have a high therapeutic index and are generally non-toxic to host cells. * **Bacitracin:** This agent inhibits the recycling of the lipid carrier (bactoprenol) required for peptidoglycan synthesis. Like beta-lactams, it targets the bacterial cell wall, a structure absent in humans, making it selectively toxic. **High-Yield NEET-PG Pearls:** * **Highest Selective Toxicity:** Drugs targeting the **cell wall** (e.g., Penicillins) are the least toxic to humans. * **Moderate Selective Toxicity:** Drugs targeting **ribosomes** (e.g., Aminoglycosides, Tetracyclines) exploit the difference between bacterial 70S and mammalian 80S ribosomes, though some toxicity occurs due to similarities with mitochondrial ribosomes. * **Lowest Selective Toxicity:** Drugs targeting **DNA or cell membranes** (e.g., Mitomycin, Polymyxins, Amphotericin B) tend to be more toxic because these targets are shared by humans.

Q: What is the drug of choice for anaerobic infections?

Metronidazole. **Explanation:** **Metronidazole** is the drug of choice for infections caused by **obligate anaerobes** (e.g., *Bacteroides fragilis*, *Clostridium difficile*, *Fusobacterium*). Its mechanism involves the reduction of its nitro group by the enzyme **pyruvate:ferredoxin oxidoreductase (PFOR)**, which is found only in anaerobic organisms. This process generates reactive free radicals that cause DNA strand breakage and cell death. **Analysis of Options:** * **Amphotericin B:** This is a polyene **antifungal** agent used for systemic fungal infections (e.g., Mucormycosis, Cryptococcosis). It has no activity against bacteria. * **Aminoglycosides (e.g., Gentamicin):** These are ineffective against anaerobes because their uptake into the bacterial cell is an **oxygen-dependent process**. They are primarily used for aerobic Gram-negative bacilli. * **Macrolides (e.g., Azithromycin):** These are mainly used for aerobic Gram-positive cocci and atypical organisms (e.g., *Mycoplasma*, *Chlamydia*). While some have minor activity against certain anaerobes, they are never the first-line choice. **High-Yield Clinical Pearls for NEET-PG:** * **Disulfiram-like reaction:** Patients must avoid alcohol while on Metronidazole due to the inhibition of aldehyde dehydrogenase. * **Coverage Rule:** For anaerobic infections "above the diaphragm" (e.g., aspiration pneumonia), **Clindamycin** is often preferred; for "below the diaphragm" (e.g., intra-abdominal abscess), **Metronidazole** is the gold standard. * **Other uses:** It is also the drug of choice for Amoebiasis, Giardiasis, Trichomoniasis, and Bacterial Vaginosis.

Q: What is the drug of choice for Gardnerella vaginalis infections?

Metronidazole. **Explanation:** **1. Why Metronidazole is the Correct Answer:** *Gardnerella vaginalis* is the primary organism associated with **Bacterial Vaginosis (BV)**. Although it is a facultative anaerobe, it thrives in the anaerobic environment created when the normal vaginal flora (*Lactobacilli*) is depleted. **Metronidazole** is the drug of choice because it is highly effective against anaerobic bacteria. It acts as a prodrug that is activated by the microbial enzyme pyruvate-ferredoxin oxidoreductase, leading to the formation of reactive toxic intermediates that cause DNA strand breakage. **2. Why the Other Options are Incorrect:** * **Ampicillin:** While it has some activity against *G. vaginalis*, it is less effective than metronidazole and is associated with higher recurrence rates. It is generally reserved for pregnant patients who cannot tolerate nitroimidazoles. * **Vancomycin:** This is a glycopeptide used primarily for Gram-positive infections (like MRSA) and *C. difficile* colitis. It has no role in treating Bacterial Vaginosis. * **Cephalosporins:** These are beta-lactam antibiotics used for a wide range of infections, but they do not provide the specific anaerobic coverage required to effectively eradicate the polymicrobial biofilm associated with BV. **3. High-Yield Clinical Pearls for NEET-PG:** * **Diagnosis:** BV is diagnosed using **Amsel’s Criteria** (requires 3 out of 4): 1. Thin, homogenous discharge; 2. Vaginal pH >4.5; 3. Positive **Whiff test** (fishy odor with 10% KOH); 4. Presence of **Clue cells** on microscopy. * **Treatment Regimen:** Oral Metronidazole 500 mg twice daily for 7 days (or 0.75% metronidazole gel). * **Important Side Effect:** Patients must be warned about the **Disulfiram-like reaction** (nausea, vomiting, flushing) if alcohol is consumed during metronidazole therapy. * **Pregnancy:** Metronidazole is safe to use in all trimesters of pregnancy for symptomatic BV.

Q: Which drug is most likely to be responsible for causing pancreatic disease?

Didanosine. ### Explanation **Correct Option: A. Didanosine** Didanosine (ddI) is a Nucleoside Reverse Transcriptase Inhibitor (NRTI) used in HIV treatment [1]. Its most notorious and dose-limiting adverse effect is **acute pancreatitis** [1], [3]. The underlying mechanism involves mitochondrial toxicity due to the inhibition of DNA polymerase-gamma, leading to pancreatic acinar cell damage [2]. Patients on Didanosine must be monitored for elevated serum amylase and lipase levels; the drug should be discontinued immediately if pancreatitis is suspected [1]. **Analysis of Incorrect Options:** * **B. Ketoconazole:** This is an azole antifungal primarily known for causing **hepatotoxicity** and inhibiting steroidogenesis (leading to gynecomastia and menstrual irregularities) by inhibiting the CYP450 system. It is not associated with pancreatic disease. * **C. Saquinavir:** This is a Protease Inhibitor (PI). While PIs are associated with metabolic complications like dyslipidemia, insulin resistance, and **lipodystrophy** (buffalo hump), they are not the primary cause of acute pancreatitis compared to Didanosine. * **D. Zidovudine (AZT):** Also an NRTI, but its hallmark toxicity is **bone marrow suppression** (anemia and neutropenia) and myopathy [3]. While it can cause lactic acidosis, it is not a classic cause of pancreatitis. **High-Yield Clinical Pearls for NEET-PG:** * **NRTI Toxicity Mnemonic:** * **D**idanosine & **S**tavudine = **D**igits and **S**tomach (**P**eripheral neuropathy and **P**ancreatitis) [3]. * **Z**idovudine = **7**idovudine (low blood counts/Anemia). * **A**bacavir = **H**ypersensitivity reaction (linked to HLA-B*5701). * Other drugs causing pancreatitis: **S**ulfonamides, **E**strogens, **V**alproic acid, **E**xenatide, **R**itonavir, **E**nalapril (**SEVERE**).

Q: Which of the following antitubercular drugs can be safely used in severe renal failure?

Rifampicin. **Explanation:** The management of tuberculosis in patients with renal impairment requires careful drug selection based on the primary route of elimination. **Why Rifampicin is the correct answer:** Rifampicin is primarily metabolized by the liver and excreted via the **bile/feces**. Since its clearance is not significantly dependent on renal function, it can be used in standard doses even in patients with severe renal failure or those on hemodialysis. Along with **Isoniazid and Pyrazinamide**, it is considered safe for use in renal failure, although the latter two are sometimes adjusted to thrice-weekly dosing in end-stage renal disease to prevent metabolite accumulation. **Why the other options are incorrect:** * **Streptomycin & Capreomycin:** Both are aminoglycosides (or aminoglycoside-like) and are strictly **excreted unchanged by the kidneys**. In renal failure, they accumulate rapidly, leading to severe ototoxicity and further nephrotoxicity. They are generally contraindicated or require extreme dose reduction and monitoring. * **Ethambutol:** Approximately 80% of ethambutol is excreted via the kidneys. In renal failure, it accumulates and significantly increases the risk of **optic neuritis**. If used, the dosing interval must be increased (e.g., thrice weekly instead of daily). **NEET-PG High-Yield Pearls:** * **Safe in Renal Failure:** Rifampicin, Isoniazid, Pyrazinamide, and Ethionamide (mainly hepatic metabolism). * **Requires Dose Adjustment:** Ethambutol and Levofloxacin. * **Avoid/Contraindicated:** Streptomycin and other injectable aminoglycosides. * **Rifampicin Fact:** It is a potent **enzyme inducer** (CYP450), but it is also the most important drug for treating "persisters" in TB due to its bactericidal action.

Q: Which among the following is the drug of choice in Mycoplasma infection?

Doxycycline. **Explanation:** The correct answer is **Doxycycline**. **1. Why Doxycycline is the Drug of Choice:** *Mycoplasma pneumoniae* is a unique pathogen characterized by the **complete absence of a cell wall**. Because it lacks a peptidoglycan layer, it is inherently resistant to all cell-wall synthesis inhibitors. Treatment must focus on protein synthesis inhibitors. **Tetracyclines (like Doxycycline)** and Macrolides (like Azithromycin) are the first-line agents. Doxycycline is highly effective due to its excellent tissue penetration and ability to inhibit the 30S ribosomal subunit. **2. Why the other options are incorrect:** * **Penicillin & Ceftriaxone (Beta-lactams):** These drugs act by inhibiting cell wall synthesis (binding to Penicillin-Binding Proteins). Since *Mycoplasma* has no cell wall, these drugs have no target site and are clinically useless. * **Cotrimoxazole:** This drug inhibits folic acid synthesis. While effective against many bacteria, it is not the standard of care for *Mycoplasma*, as Tetracyclines and Macrolides show superior clinical outcomes. **3. High-Yield Clinical Pearls for NEET-PG:** * **Atypical Pneumonia:** *Mycoplasma* is the most common cause of "Walking Pneumonia," typically presenting with a persistent dry cough and patchy infiltrates on X-ray that look worse than the patient’s clinical state. * **Diagnosis:** The **Cold Agglutinin Test** (IgM antibodies) is a classic bedside test, though PCR is now the gold standard. * **Complications:** Look for **Erythema Multiforme** or Stevens-Johnson Syndrome as a rare but high-yield dermatological association. * **Alternative:** In children and pregnant women (where Tetracyclines are contraindicated), **Azithromycin** is the preferred alternative.

Question 1

All of the following statements regarding the development of resistance against penicillins is true EXCEPT?

Accepted Answer

Bacteria may develop alternate metabolic pathways.

Answer

Bacteria may develop inactivating enzymes called penicillinases.

Answer

Bacteria may develop altered penicillin binding proteins.

Answer

Bacteria may become less permeable to penicillins.

Question 2

An elderly patient with tubercular meningitis is not responding to the current treatment. A new combination of drugs needs to be prescribed for a prolonged period. Which one of the following drugs should not be prescribed in this case?

Accepted Answer

Dehydrostreptomycin

Answer

Rifampicin

Answer

Ofloxacin

Answer

Pyrazinamide

Question 3

Gynaecomastia is a side effect of which of the following medications?

Accepted Answer

Rifampicin

Answer

Digitalis

Answer

Ketoconazole

Answer

Spironolactone

Question 4

Which antibiotic can cause respiratory failure when used in patients with myasthenia gravis?

Accepted Answer

Telithromycin

Answer

Clindamycin

Answer

Linezolid

Answer

Tetracycline

Question 5

Ideally, an antibiotic should focus on a microbial target not found in mammalian cells. By this standard, which of the following antibiotic agents would be expected to be most toxic to humans?

Accepted Answer

Mitomycin

Answer

Penicillin

Answer

Cephalosporin

Answer

Bacitracin

Question 6

What is the drug of choice for anaerobic infections?

Accepted Answer

Metronidazole

Answer

Amphotericin B

Answer

Aminoglycoside

Answer

Macrolide

Question 7

What is the drug of choice for Gardnerella vaginalis infections?

Accepted Answer

Metronidazole

Answer

Ampicillin

Answer

Vancomycin

Answer

Cephalosporin

Question 8

Which drug is most likely to be responsible for causing pancreatic disease?

Accepted Answer

Didanosine

Answer

Ketoconazole

Answer

Saquinavir

Answer

Zidovudine

Question 9

Which of the following antitubercular drugs can be safely used in severe renal failure?

Accepted Answer

Rifampicin

Answer

Streptomycin

Answer

Ethambutol

Answer

Capreomycin

Question 10

Which among the following is the drug of choice in Mycoplasma infection?

Accepted Answer

Doxycycline

Answer

Penicillin

Answer

Ceftriaxone

Answer

Cotrimoxazole

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?